Identification and control of a poliomyelitis outbreak in Xinjiang, China
- PMID: 24256377
- DOI: 10.1056/NEJMoa1303368
Identification and control of a poliomyelitis outbreak in Xinjiang, China
Abstract
Background: The last case of infection with wild-type poliovirus indigenous to China was reported in 1994, and China was certified as a poliomyelitis-free region in 2000. In 2011, an outbreak of infection with imported wild-type poliovirus occurred in the province of Xinjiang.
Methods: We conducted an investigation to guide the response to the outbreak, performed sequence analysis of the poliovirus type 1 capsid protein VP1 to determine the source, and carried out serologic and coverage surveys to assess the risk of viral propagation. Surveillance for acute flaccid paralysis was intensified to enhance case ascertainment.
Results: Between July 3 and October 9, 2011, investigators identified 21 cases of infection with wild-type poliovirus and 23 clinically compatible cases in southern Xinjiang. Wild-type poliovirus type 1 was isolated from 14 of 673 contacts of patients with acute flaccid paralysis (2.1%) and from 13 of 491 healthy persons who were not in contact with affected persons (2.6%). Sequence analysis implicated an imported wild-type poliovirus that originated in Pakistan as the cause of the outbreak. A public health emergency was declared in Xinjiang after the outbreak was confirmed. Surveillance for acute flaccid paralysis was enhanced, with daily reporting from all public and private hospitals. Five rounds of vaccination with live, attenuated oral poliovirus vaccine (OPV) were conducted among children and adults, and 43 million doses of OPV were administered. Trivalent OPV was used in three rounds, and monovalent OPV type 1 was used in two rounds. The outbreak was stopped 1.5 months after laboratory confirmation of the index case.
Conclusions: The 2011 outbreak in China showed that poliomyelitis-free countries remain at risk for outbreaks while the poliovirus circulates anywhere in the world. Global eradication of poliomyelitis will benefit all countries, even those that are currently free of poliomyelitis.
Comment in
-
No country is safe without global eradication of poliomyelitis.N Engl J Med. 2013 Nov 21;369(21):2045-6. doi: 10.1056/NEJMe1311591. N Engl J Med. 2013. PMID: 24256383 No abstract available.
-
Polio has not gone away.Arch Dis Child. 2014 Feb;99(2):170. doi: 10.1136/archdischild-2013-305790. Arch Dis Child. 2014. PMID: 24420611 No abstract available.
Similar articles
-
Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.J Med Virol. 2008 Aug;80(8):1477-88. doi: 10.1002/jmv.21230. J Med Virol. 2008. PMID: 18551602
-
Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.Science. 2002 Apr 12;296(5566):356-9. doi: 10.1126/science.1068284. Epub 2002 Mar 14. Science. 2002. PMID: 11896235
-
Importation of wild poliovirus into Qinghai Province--China, 1999.MMWR Morb Mortal Wkly Rep. 2000 Feb 18;49(6):113-4. MMWR Morb Mortal Wkly Rep. 2000. PMID: 11243437
-
[Worldwide eradication of poliomyelitis].Wien Klin Wochenschr. 2001 Oct 30;113(20-21):839-45. Wien Klin Wochenschr. 2001. PMID: 11732120 Review. German.
-
Circulating vaccine-derived polioviruses: current state of knowledge.Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106296 Free PMC article. Review.
Cited by
-
A review of documents prepared by international organizations about influenza pandemics, including the 2009 pandemic: a bibliometric analysis.BMC Infect Dis. 2018 Aug 8;18(1):383. doi: 10.1186/s12879-018-3286-3. BMC Infect Dis. 2018. PMID: 30089459 Free PMC article. Review.
-
Perspective: Elimination round.Nature. 2014 Mar 6;507(7490):S16. doi: 10.1038/507s16a. Nature. 2014. PMID: 24611173 No abstract available.
-
Effects of maternal antibodies in infants on the immunogenicity and safety of inactivated polio vaccine in infants.Hum Vaccin Immunother. 2022 Nov 30;18(5):2050106. doi: 10.1080/21645515.2022.2050106. Epub 2022 Apr 8. Hum Vaccin Immunother. 2022. PMID: 35394898 Free PMC article. Clinical Trial.
-
Landscape of emerging and re-emerging infectious diseases in China: impact of ecology, climate, and behavior.Front Med. 2018 Feb;12(1):3-22. doi: 10.1007/s11684-017-0605-9. Epub 2018 Jan 24. Front Med. 2018. PMID: 29368266 Free PMC article. Review.
-
Molecular characterization of enteroviruses including a new type EV-C99 isolated from Xinjiang students in Shandong, China in 2011.Sci Rep. 2014 Oct 9;4:6564. doi: 10.1038/srep06564. Sci Rep. 2014. PMID: 25298041 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical